Contact

Email

julie.mcmullen@unimelb.edu.au

Credentials

Position
Honorary (Principal Fellow)
Baker Department of Cardiometabolic Health
Education
PhD
University of New South Wales
Bachelors Degree (Honours)
University of New South Wales

Prof Julie McMullen

Honorary (Principal Fellow)
Baker Department of Cardiometabolic Health
32 Scholarly works
1 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Calcium-dependent regulation of physiological vs pathological cardiomyocyte hypertrophy
    DOI: 10.1016/j.bbamcr.2025.120046
  • 2025

    Journal article

    Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
    DOI: 10.1016/j.jshs.2025.101023
  • 2025

    Journal article

    Generation and evaluation of a novel PI3K-targeting gene therapy in the failing mouse heart and healthy sheep heart
    DOI: 10.1016/j.jmccpl.2025.100478
  • 2025

    Journal article

    Reduced PI3K and Anthracycline Treatment Prevents Exercise-Induced Cardiac Hypertrophy
    DOI: 10.1016/j.hlc.2025.06.384
  • 2025

    Journal article

    An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy
    DOI: 10.1016/j.jmccpl.2024.100273
  • 2025

    Journal article

    Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP
    DOI: 10.1007/978-1-0716-4217-7_7
  • 2023

    Research grants (other domestic)

    Prospective Evaluation of Plasma Markers of PI3K Activity in the Healthy and Diseased Heart to Assess Cardiac Risk and Identify Future Treatment Strategies
Julie McMullen

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    Sex-specific regulation of the cardiac transcriptome by the protein phosphatase 2A regulatory subunit B55α
    DOI: 10.1038/s44324-024-00033-2
  • 2024

    Journal article

    Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation
    DOI: 10.1042/CS20240178
  • 2024

    Journal article

    A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
    DOI: 10.1007/s00109-023-02397-2
  • 2024

    Journal article

    Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation
    DOI: 10.1152/ajpheart.00437.2023